Systematic review and meta‐analysis identify significant relationships between clinical anxiety and lower urinary tract symptoms
Abstract Background Lower urinary tract symptoms (LUTS), such as voiding symptoms, overactive bladder, and interstitial cystitis, and anxiety disorders are often comorbid conditions in patients. However, the existing evidence regarding the rates and nature of the co‐occurrence of these conditions ha...
Main Authors: | Behrang Mahjani, Lotta Renström Koskela, Anita Batuure, Christina Gustavsson Mahjani, Magdalena Janecka, Christina M. Hultman, Abraham Reichenberg, Joseph D. Buxbaum, Olof Akre, Dorothy E. Grice |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.2268 |
Similar Items
-
Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action
by: Jia-Fong Jhang, et al.
Published: (2016-04-01) -
Role of liposome in treatment of overactive bladder and interstitial cystitis
by: Shih-Ya Hung, et al.
Published: (2015-03-01) -
Effect of Low-Dose Triple Therapy Using Gabapentin, Amitriptyline, and a Nonsteroidal Anti-Inflammatory Drug for Overactive Bladder Symptoms in Patients With Bladder Pain Syndrome
by: Whi-An Kwon, et al.
Published: (2013-06-01) -
Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
by: Luke Grundy, et al.
Published: (2018-12-01) -
Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction
by: Joseph J. Janicki, et al.
Published: (2016-03-01)